Open AccessDual vs Single Protease Inhibitor Therapy Following Antiretroviral Treatment Failure<SUBTITLE>A Randomized Trial</SUBTITLE>
Author(s) -
Scott M. Hammer
Publication year - 2002
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.288.2.169
Subject(s) - indinavir , medicine , nelfinavir , saquinavir , viral load , amprenavir , efavirenz , placebo , ritonavir , regimen , stavudine , gastroenterology , virology , pharmacology , virus , protease , pathology , biochemistry , chemistry , alternative medicine , hiv 1 protease , antiretroviral therapy , enzyme
Management of antiretroviral treatment failure in patients receiving protease inhibitor (PI)-containing regimens is a therapeutic challenge.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom